Venous Thrombosis Clinical Trials

Birmingham :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Birmingham : University of Alabama at Birmingham

Clarification of Optimal Anticoagulation Through Genetics

Dothan :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Montgomery :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Glendale : Arrowhead Hospital/Phoenix Heart, PLLC

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Phoenix : Phoenix Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

Little Rock : Arkansas Children's Hospital Research Institute

Treatment of Blood Clots in Children With Cancer

La Mesa :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Long Beach :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Los Angeles :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Orange : St. Joseph Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Palo Alto : Stanford University Medical Center

Treatment of Blood Clots in Children With Cancer

View More »

San Diego :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

San Diego : Rady Children's Hospital UCSD

Evaluation of the Duration of Therapy for Thrombosis in Children

San Francisco : University of California San Francisco

Clarification of Optimal Anticoagulation Through Genetics

Stanford :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Stanford : Stanford University Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Denver : University of Colorado School of Medicine

Evaluation of the Duration of Therapy for Thrombosis in Children

Wheat Ridge :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Danbury : Danbury Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Norwich : Eastern Connecticut Hematology and Oncology Associates

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Newark : Christiana Care Health Systems

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Washington : George Washington University, Children's National Medical Center

Evaluation of the Duration of Therapy for Thrombosis in Children

Washington : Georgetown University Lombardi Cancer Center

Treatment of Blood Clots in Children With Cancer

Bay Pines :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Clearwater :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Clearwater :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Ft. Myers :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Gainesville : University of Florida

Clarification of Optimal Anticoagulation Through Genetics

View More »

Jacksonville :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Jacksonville : Nemours Children's Clinic/Jacksonville

Treatment of Blood Clots in Children With Cancer

Orlando : Florida Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Sarasota :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Sarasota :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

St. Petersburg : All Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

Tampa : Pepin Heart Hospital / University Community Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Tampa : St. Joseph's Children's Hospital of TampaPediatric Hematology/Oncology Research Department

Treatment of Blood Clots in Children With Cancer

Vero Beach :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Atlanta : Emory University

Treatment of Blood Clots in Children With Cancer

Augusta : Georgia Health Sciences University

Clarification of Optimal Anticoagulation Through Genetics

Decatur :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Jonesboro :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Chicago : University of Illinois at Chicago

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Chicago :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Chicago : Rush University Medical Center

Treatment of Blood Clots in Children With Cancer

Hinsdale : Adventist Midwest Health

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Oak Park :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Springfield : Southern Illinois University

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Winfield : Central DuPage Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Carmel :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Indianapolis : CorVasc

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Lafayette :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Iowa City : University of Iowa Carver's College of Medicine

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Windsor Heights :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Topeka :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Florence : St. Elizabeth Healthcare of Northern Kentucky

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Louisvile : Kosair Charities Pediatric Clinical Research Unit- University of Louisville

Treatment of Blood Clots in Children With Cancer

Paducah :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Covington :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

New Orleans : Tulane University Health Science Center

Clarification of Optimal Anticoagulation Through Genetics

Portland : Maine Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Annapolis :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Baltimore : Johns Hopkins Bayview Medical Center

A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients

Baltimore :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Baltimore : University of Maryland School of Medicine

Clarification of Optimal Anticoagulation Through Genetics

Randallstown :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Boston : Massachusetts General Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Ann Arbor : Ann Arbor Veteran's Administration Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Ann Arbor : University of Michigan Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Detroit :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Detroit : Henry Ford Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Detroit : Henry Ford Hospital

Clarification of Optimal Anticoagulation Through Genetics

View More »

Detroit : Children's Hospital of Michigan, Wayne State University

Evaluation of the Duration of Therapy for Thrombosis in Children

East Lansing : Michigan State University

Evaluation of the Duration of Therapy for Thrombosis in Children

Duluth :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Rochester : Mayo Clinic

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Rochester : Mayo Clinic College of Medicine

Clarification of Optimal Anticoagulation Through Genetics

Picayune :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

St. Louis :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

St. Louis : Washington University School of Medicine

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

St. Louis : Washington University School of Medicine

Clarification of Optimal Anticoagulation Through Genetics

Butte :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Butte :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Lincoln : Saint Elizabeth Regional Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Omaha :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Reno :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Teaneck : Holy Name Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Albuquerque : University of New Mexico

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Albuquerque : University of New Mexico

Treatment of Blood Clots in Children With Cancer

Bronx : Montefiore Medical Center

Clarification of Optimal Anticoagulation Through Genetics

Buffalo : Roswell Park Cancer Institute

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

New York : Cornell Weill Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

New York : Mount Sinai School of Medicine

Clarification of Optimal Anticoagulation Through Genetics

Rochester : Rochester General Hospital

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

View More »

Rochester : University of Rochester Medical Center

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Staten Island :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Staten Island : Staten Island University Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Chapel Hill : University of North Carolina at Chapel Hill

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Durham :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Durham : Duke University School of Medicine

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Durham :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Durham : Duke University

Clarification of Optimal Anticoagulation Through Genetics

View More »

Durham : Duke University

Evaluation of the Duration of Therapy for Thrombosis in Children

Durham : Duke Children's Hospital

Treatment of Blood Clots in Children With Cancer

Winston Salem : Wake Forest University Baptist Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Winston-Salem : Forsyth Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Cincinatti : Good Samaritan Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Cleveland :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Cleveland : Cleveland Clinic

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Colombus : Univeristy Medical Center

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Columbus : Riverside Methodist Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

View More »

Columbus : Nationwide Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

Toledo : Jobst Vascular Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Portland : Oregon Health & Science University

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Portland : Oregon Health and Science University

Treatment of Blood Clots in Children With Cancer

West Reading : The Reading Hospital and Medical Center Clinical Trials Office

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

View More »

Bethlehem : St. Luke's Hospital and Health Network

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Camp Hill :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Camp Hill :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Ephrata :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Philadelphia : Albert Einstein Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Philadelphia : Temple University Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Philadelphia : Hospital of the University of Pennsylvania

Clarification of Optimal Anticoagulation Through Genetics

Pittsburgh : Allegheny General Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : University of Pittsburgh Medical Center Presbyterian Shadyside

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Pittsburgh : The Western Pennsylvania Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Sellersville :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

West Reading : The Reading Hospital and Medical Center

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Providence : Rhode Island Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Charleston : Medical University of South Carolina

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Charleston : Medical Center of South Carolina

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Orangeburg :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Memphis : St. Jude Children's Research Hospital

Treatment of Blood Clots in Children With Cancer

Nashville : Vanderbilt University

Clarification of Optimal Anticoagulation Through Genetics

Nashville : Vanderbilt University

Evaluation of the Duration of Therapy for Thrombosis in Children

Bellaire :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Corsicana :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Dallas :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Dallas : University of Texas Southwestern

Evaluation of the Duration of Therapy for Thrombosis in Children

Fort Worth : Cook Children's Hospital

Evaluation of the Duration of Therapy for Thrombosis in Children

View More »

Forth Worth : Cook Children's Medical Center

Treatment of Blood Clots in Children With Cancer

Galveston : University of Texas Medical Branch

Clarification of Optimal Anticoagulation Through Genetics

Houston : Texas Children's Cancer Center, Baylor College of Medicine

Evaluation of the Duration of Therapy for Thrombosis in Children

Houston : 1160.145.00001 Boehringer Ingelheim Investigational Site

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

San Antonio :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Murray : Intermountain Medical Center

Clarification of Optimal Anticoagulation Through Genetics

Salt Lake City : University of Utah

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Salt Lake City : University of Utah Health Care

Clarification of Optimal Anticoagulation Through Genetics

Charlottesville : University of Virginia Health System

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Fredericksburg :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Richmond :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Tacoma : MultiCare Health System

A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).

View More »

Tacoma :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Marshfield : Marshfield Clinical Research Foundation

Clarification of Optimal Anticoagulation Through Genetics

Milwaukee : Medical College of Wisconsin/Froedtert Hospital

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Wauwatosa : Medical College of Wisconsin, Blood Center of Wisconsin

Evaluation of the Duration of Therapy for Thrombosis in Children

Herston :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Lismore :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Melbourne : Royal Melbourne hospital

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.

Parkville :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Redcliffe :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Graz :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Graz :

Oral Rivaroxaban in Children With Venous Thrombosis

Graz : 1160.86.43001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Wien :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Wien :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Wien : 1160.89.43001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Wien : 1160.86.43003 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Brussel : 1160.89.32003 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Bruxelles :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Ghent : Drug Research Unit Ghent

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

Huy :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Leper :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Leuven :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Yvoir :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Gabrovo :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Pleven :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Sofia :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Charlottetown : 1160.86.01003 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Edmonton :

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Edmonton :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Edmonton : 1160.89.00002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Hamilton :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

View More »

Hamilton : St. Joseph's Healthcare Hamilton

The Risk of Venous Clotting in Patients After Renal Transplant

Hamilton : St Joseph's Healthcare Hamilton

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Montréal : Maisonneuve Rosemont Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Oshawa : Isis Investigational Site

Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS FXI Rx in Total Knee Arthroplasty

Ottawa : Ottawa Hospital Research Institute (OHRI)

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Ottawa : 1160.89.00001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Red Deer : 1160.86.01001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Toronto : St. Michael's Hospital

Atorvastatin for the Treatment of Retinal Vein Occlusion

Toronto : 1160.89.00005 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Vancouver : Diamond Health Care Centre

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Krapinske Toplice :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Rijeka :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Zagreb :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Brno : 1160.86.42001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Kyjov :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Liberec :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Litomysl :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Olomouc :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Olomouc : 1160.86.42003 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Ostrava :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Prague : 1160.86.42004 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Prague 5 : 1160.86.42002 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Praha 1 :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Praha 10 :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Usti nad Labem :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Zlin :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Frederiksberg :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Haderslev :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Hellerup :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Hillerod :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Hvidovre :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Kobenhavn NV :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Silkeborg :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Slagelse :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Tallinn :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Tartu :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Angers : CHU d'Angers

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Angoulême : CH d'Angoulême

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Brest :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Brest : HIA Clermont-Tonnerre

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Brest : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

View More »

Corbeil Essonne : CH de Corbeil Essonne

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Dijon : CHU de Dijon

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Dijon : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Grenoble : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Marseille : 1160.89.33002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Montauban : CH Montauban

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Montelimar : Cabinet

Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome

Morlaix : CH de Morlaix

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Paris : Medical Intensive Care Unit

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Paris : 1160.89.33001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Poitiers : CHU de Poitiers

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Saint Malo : CH de St Malo

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Tours : CHU de Tours

Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)

Baesweiler : Chriurgische Praxisklinik

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Berlin :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Berlin : DEutsches Rotes Kreuz Schwesternschaft Berlin Gemeinnütziges Krankenhaus GmbH

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Bonn :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Bonn : Universitäts-Hautklinik Bonn

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

View More »

Dresden :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Dresden : Universitätsklinikum Dresden

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Freiburg : Hautarztpraxis

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Karlsbach : Akademie für Gefäßkrankheiten e.V.

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Magdeburg :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Mühldorf am Inn : Kardiologie Mühldorf am Inn

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

München : Gemeinschaftspraxis Mietaschk, Bilderling, Kaiser, Tato

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Neuss :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Witten :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Balassagyarmat :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Afula :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Ashkelon :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Haifa :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Holon :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Jerusalem :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Kfar Saba :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Nahariya :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Safed :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Tel Aviv :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Tel Hashomer :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Zerifin :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Bollate :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Bologna : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Castelfranco Veneto :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Genova :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Milan : IRCCS H San Raffaele

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

View More »

Milano :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Parma :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Piacenza :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Roma :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Roma : 1160.89.39001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Torino :

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Varese :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Vittorio Veneto TV :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Chuo-ku : St. Luke's International Hospital

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Tsu : Mie University Hospital

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Many Locations :

Xarelto Regulatory Post-Marketing Surveillance

Daugavpils :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Liepaja :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Riga :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Riga : 1160.89.37101 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Valmiera :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Kaunas :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Klaipeda :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Siauliai :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Vilnius :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Vilnius : 1160.89.37001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Nijmegen : 1160.89.31003 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Utrecht : 1160.89.31004 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Bergen : 1160.89.47001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Bialystok :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Bydgoszcz :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Czeladz :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Gdansk :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Krakow :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Skierniewice :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Tarnobrzeg :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Warszawa :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Kemerovo :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Many locations :

Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)

Samara :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

St. Petersburg :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Yaroslavl :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Singapore :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Cape Town :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Johannesburg :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Alicante : University Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Barcelona :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

L'Hospitalet de Llobregat :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Madrid :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Madrid :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

View More »

Madrid : 1160.89.34002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Madrid : 1160.89.34001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Majadahonda :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Orihuela :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Sabadell :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

San Sebastián de los Reyes :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Sant Boi de Llobregat :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Soria : General Hospital

STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism

Tarragona :

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Hässleholm : 1160.86.46002 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Mölndal : 1160.86.46001 Boehringer Ingelheim Investigational Site

Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate

Stockholm : Karolinska University Hospital

Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture

Many Locations :

Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy

Zürich : 1160.89.41001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Bangkok : 1160.89.66001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Tunis : Hospital Charle Nicolle

Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin

Dnipropetrovsk : 1160.89.38001 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Lugansk : 1160.89.38002 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Vinnytsya : 1160.89.38003 Boehringer Ingelheim Investigational Site

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age